Documentation saves the day
Learn how documentation can significantly benefit patients and providers.
Sex differences in dermatologic conditions
Data has indicated an increased prevalence of atopic dermatitis among female patients compared to male patients.
Insurance coverage and postpartum care for immigrants
A recent study found immigrants are less likely to receive postpartum care in states that restrict insurance coverage.
The impact of stillbirths on patients and providers
Stillbirths are one of the most tragic situations for obstetrician-gynecologists to encounter, making awareness vital.
How to have difficult discussions
What are the key factors of communication with a patient who is fearing symptom progression or near death?
HHS launching tour for maternal health
The Maternal Outcomes Matter Showers Tour will encourage the spread of educational information and health care services related to maternal health.
Curcumin does not impact bleeding from contraceptive implant
In a recent study, rates of abnormal bleeding among etonogestrel contraceptive implant users did not differ between a curcumin and a placebo group.
Vaginal estrogen effective against recurrent UTIs
In a recent study, recurrent urinary tract infection rates decreased by over 50% in women using vaginal estrogen.
HPV genotypes screening improve cervical cancer prediction
In a recent study, the prediction values of cervical cancer prediction models increased significantly when human papillomavirus genotypes were included in the evaluation.
Nanoparticles effective at treating vulvovaginal candidiasis
In a recent study, miconazole-loaded nanoparticles coated with hyaluronic acid were indicated as effective for treating vulvovaginal candidiasis.
Breast cancer treatment increased biological aging
In a recent study, women with breast cancer experienced increased biological aging when treated with radiation therapy.
Infertility, miscarriage, and stillbirth increase early menopause risk
In a recent study, premature and early menopause were more common in women with a history of infertility, miscarriage, or stillbirth.
First over-the-counter oral contraceptive approved by FDA
Norgestrel (Opill; HRA Pharma) is the first nonprescription oral contraceptive approved for use in the United States.
2 Clarke Drive Cranbury, NJ 08512